Amisulpride

BARHEMSYS ® is indicated in adults for: prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.
treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.
Do not take if: BARHEMSYS is contraindicated in patients with known hypersensitivity to amisulpride.

What it is used for

BARHEMSYS ® is indicated in adults for:

prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.
treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.

Who should not take it

BARHEMSYS is contraindicated in patients with known hypersensitivity to amisulpride.

Storing it

Store vials at 20°C to 25°C (68°F to 77°F).

Protect from light. Administer BARHEMSYS within 12 hours after the vial is removed from the protective carton.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Amisulpride; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/amisulpride
APA 7th: sofidex. (2026, August 2). Amisulpride. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/amisulpride
AMA 11th: Amisulpride. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/amisulpride

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.